According to Tonix Pharmaceuticals's latest financial reports the company's current EPS (TTM) is -12,70 โฌ. In 2022 the company made an earnings per share (EPS) of -23,57 โฌ an increase over its 2021 EPS that were of -48,10 โฌ.
Year | EPS | Change |
---|---|---|
2023 (TTM) | -13,10 โฌ | -44.44% |
2022 | -23,57 โฌ | -50.99% |
2021 | -48,10 โฌ | -67.05% |
2020 | -145,96 โฌ | -97.43% |
2019 | -5.678 โฌ | -87.28% |
2018 | -44.626 โฌ | -27.29% |
2017 | -61.379 โฌ | -79.07% |
2016 | -293.216 โฌ | -42.41% |
2015 | -509.139 โฌ | 2.98% |
2014 | -494.398 โฌ | -19.56% |
2013 | -614.583 โฌ | -40.36% |
2012 | -1.030.515 โฌ | -0.49% |
2011 | -1.035.574 โฌ | -42.94% |
2010 | -1.814.777 โฌ | 6264.1% |
2009 | -28.516 โฌ | 46.06% |
2008 | -19.524 โฌ |